About Lindy Biosciences
Lindy Biosciences is a private company based in Morrisville, North Carolina. It has reported $5,667,319 raised in four offerings on Form D since March 2018. Its chief executive is Deborah Bitterfield.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2024 | Mar 19, 2024 | $1,709,637of $2.5M target | 10 | $170K | Equity, OptionsRule 506(b) | Form D ↗ |
| Mar 11, 2022 | Mar 16, 2022 | $3,259,946of $5.0M target | 29 | $112K | EquityRule 506(b) | Form D ↗ |
| Jan 11, 2019 | Jan 22, 2019 | $547,736of $1.6M target | 6 | $91,289 | EquityRule 506(b) | Form D ↗ |
| Mar 6, 2018 | Mar 16, 2018 | $150,000fully sold | 1 | $150K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, four offerings | $5,667,319 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lindy Biosciences's Form D filed Mar 19, 2024.
KL
Karen LeVert
Director
OF
Omar Flores
Executive officer and director
DB
Deborah Bitterfield
CEO and director
JW
Earlier filings also listed Sreekar Gadde (director, last listed Mar 2022).